Questions people ask first.
Start here for beta access, privacy, tracking, evidence labels, and the boundaries of what Peptide-IQ does.
What is Peptide-IQ?
Peptide-IQ is an educational research and tracking workspace for people exploring peptide protocols. It helps users compare evidence labels, build logs, track side effects, and review personal trends.
Is Peptide-IQ medical advice?
No. Peptide-IQ does not diagnose, prescribe, recommend dosing, or replace a licensed clinician.
Does Peptide-IQ sell peptides?
No. It is not a marketplace, pharmacy, vendor ranking engine, or purchasing tool.
How does the beta work?
The first release is iOS-first through TestFlight. Testers get a private invite, use the app for a few weeks, and send feedback on research, protocol building, dose logging, and trends.
Will Android be supported?
Android is on the roadmap after the iOS beta validates the core tracking workflow.
What data does Peptide-IQ track?
Users can track protocols, dose logs, side effects, subjective metrics, and progress notes. Future anonymous community insights should be opt-in.
How are evidence labels different from recommendations?
Evidence labels summarize the strength and limits of available information. They do not tell a user what to take.